Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Clinical trial NCT07227571 · RECRUITING
Trial details
- NCT number
- NCT07227571
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2044-01-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.